
COVID-19: According to Serum Institute of India CEO Adar Poonawalla, Covovax would be approved as a booster in 10 to 15 days
Adar Poonawalla, chief executive officer of Serum Institute of India, stated on Sunday that the Covovax vaccine will be approved as a booster in the upcoming 10 to 15 days and added that it is effective against the Omicron form of coronavirus.